Skip to main content

Advertisement

Log in

The Inhibitory Effect of Platelet-Rich Plasma on Botulinum Toxin Type-A: An Experimental Study in Rabbits

  • Original Article
  • Experimental/Special Topics
  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

Background

Combination treatments of botulinum toxin type-A and other rejuvenation agents or instruments are gradually becoming more popular. After observing a high incidence of therapy failure following simultaneous applications of botulinum toxin type-A and platelet-rich plasma mesotherapy, we aimed to investigate whether PRP has an inhibitory effect on botulinum toxin type-A.

Methods

Twenty-four New Zealand white rabbits were divided into 4 groups, and the anterior auricular muscle and overlying skin were used for injections. Groups I and II both received onabotulinumtoxinA intramuscular injections. In addition, autologous platelet-rich plasma mesotherapy was performed in Group I while Group II received saline mesotherapy. Group III was designed as the in vitro mixture group in which onabotulinumtoxinA and platelet-rich plasma were mixed and then administered intramuscularly. Group IV received saline within the mixture instead of platelet-rich plasma. The contralateral ears of all the rabbits served as control and were only treated with onabotulinumtoxinA. Visual evaluation of ear positions and electroneuromyographic studies were done prior to all procedures and at day 14. Anterior auricular muscles were harvested at day 14 and were evaluated with quantitative real-time PCR.

Results

Visual and electroneuromyographic studies revealed less onabotulinumtoxinA activity in Groups I and III. When platelet-rich plasma was administered through skin mesotherapy, onabotulinumtoxinA activity failure was more severe in comparison with direct contact. No significant difference in SNAP-25 mRNA expression through quantitative real-time PCR was observed between groups.

Conclusion

Although we could not explain the exact mechanism underlying this interaction, platelet-rich plasma applications result in less onabotulinumtoxinA muscle paralysis activity.

No Level Assigned

This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors http://www.springer.com/00266.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. American Society of Plastic Surgeons 2013 Plastic Surgery Statistics Report. http://www.plasticsurgery.org/Documents/news-resources/statistics/2013-statistics/cosmetic-procedures-national-trends-2013.pdf

  2. Man D, Plosker H, Winland-Brown JE (2001) The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 107(1):229–237

    Article  CAS  PubMed  Google Scholar 

  3. Naumann M, Carruthers A, Carruthers J et al (2010) Meta-analysis of neutralizing antibody conversion with BoNT-A (BOTOX®) across multiple indications. Mov Disord 25(13):2211–2218

    Article  PubMed  Google Scholar 

  4. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36

    Article  PubMed Central  PubMed  Google Scholar 

  5. Findikcioglu K, Findikcioglu F, Yavuzer R, Elmas C, Atabay K (2009) Effect of platelet-rich plasma and fibrin glue on healing of critical-size calvarial bone defects. J Craniofac Surg 20(1):34–40

    Article  PubMed  Google Scholar 

  6. Cho JM, Lee YH, Baek RM, Lee SW (2011) Effect of platelet-rich plasma on ultraviolet b-induced skin wrinkles in nude mice. J Plast Reconstr Aesthet Surg 64(2):e31–e39

    Article  PubMed  Google Scholar 

  7. Cervelli V, Palla L, Pascali M, De Angelis B, Curcio BC, Gentile P (2009) Autologous platelet-rich plasma mixed with purified fat graft in aesthetic plastic surgery. Aesthetic Plast Surg 33(5):716–721

    Article  PubMed  Google Scholar 

  8. Sariguney Y, Yavuzer R, Elmas C, Yenicesu I, Bolay H, Atabay K (2008) Effect of platelet-rich plasma on peripheral nerve regeneration. J Reconstr Microsurg 24(3):159–167

    Article  PubMed  Google Scholar 

  9. Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, Lee Y (2011) Can Platelet-rich Plasma Be Used for Skin Rejuvenation?. Evaluation of Effects of Platelet-rich Plasma on Human Dermal Fibroblast. Ann Dermatol 23(4):424–431

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Bulam H, Ayhan S, Sezgin B, Özmen S, Çenetoğlu S (2013) Mesotherapy: is it a miracle or an air bubble on the tip of the needle? Turk Plast Surg 21(2):16–19

    Google Scholar 

  11. Rohrich RJ (2005) Mesotherapy: what is it? Does it work? Plast Reconstr Surg 115(5):1425

    Article  CAS  PubMed  Google Scholar 

  12. Taieb M, Gay C, Sebban S, Secnazi P (2012) Hyaluronic acid plus mannitol treatment for improved skin hydration and elasticity. J Cos-met Dermatol 11(2):87–92

    Article  Google Scholar 

  13. Lacarrubba F, Tedeschi A, Nardone B, Micali G (2008) Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echo genic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatol Ther 21(3):1–5

    Article  Google Scholar 

  14. El-Domyati M, El-Ammawi TS, Moawad O et al (2012) Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation. Int J Dermatol 51(8):913–919

    Article  PubMed Central  PubMed  Google Scholar 

  15. Amin SP, Phelps RG, Goldberg DJ (2006) Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg 32(12):1467–1472

    CAS  PubMed  Google Scholar 

  16. Herreros FO, Moraes AM, Velho PE (2011) Mesotherapy: a bibliographical review. An Bras Dermatol 86(1):96–101

    Article  PubMed  Google Scholar 

  17. Baker AH, Edwards DR, Murphy G (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115(19):3719–3727

    Article  CAS  PubMed  Google Scholar 

  18. Miyoshi S, Shinoda S (1991) Alpha-macroglobulin-like plasma inactivator for Vibrio vulnificus metalloprotease. J Biochem 110(4):548–552

    CAS  PubMed  Google Scholar 

  19. Saidi N, Samel M, Siigur J, Jensen PE (1999) Lebetase, an alpha (beta)-fibrin(ogen)olytic metalloproteinase of Viperalebetina snake venom, is inhibited by human alpha-macroglobulins. Biochim Biophys Acta 1434(1):94–102

    Article  CAS  PubMed  Google Scholar 

  20. Sjoberg J, Kanje M (1989) Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res 485:102–108

    Article  CAS  PubMed  Google Scholar 

  21. Sondell M, Lundborg G, Kanje M (1999) Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 19:5731–5740

    CAS  PubMed  Google Scholar 

  22. Jabor MA, Kaushik R, Shayani P, Ruiz-Razura A, Smith BK, Morimoto KW, Cohen BE (2003) Efficacy of reconstituted and stored botulinum toxin type A: an electrophysiologic and visual study in the auricular muscle of the rabbit. Plast Reconstr Surg 111(7):2419–2426

    Article  PubMed  Google Scholar 

  23. Elmas C, Ayhan S, Tuncer S, Erdogan D, Calguner E, Basterzï Y, Gozil R, Bahcelioglu M (2007) Effect of fresh and stored botulinum toxin a on muscle and nerve ultrastructure: an electron microscopic study. Ann Plast Surg 59(3):316–322

    Article  CAS  PubMed  Google Scholar 

  24. Gorgu M, Silistreli O, Karantinaci B, Ayhan M, Ozdemirkıran T, Celebisoy M (2006) Interaction of botulinum toxin type a with local anesthetic agents: an experimental study in rabbits. Aesth Plast Surg. 30:59–64

    Article  Google Scholar 

  25. Capková K, Hixon MS, Pellett S, Barbieri JT, Johnson EA, Janda KD (2010) Benzylidenecyclopentenediones: first irreversible inhibitors against botulinum neurotoxin A’s zinc endopeptidase. Bioorg Med Chem Lett 20(1):206–208

    Article  PubMed Central  PubMed  Google Scholar 

  26. Vartanian AJ, Dayan SH (2005) Complications of botulinumtoxin A use in facial rejuvenation Facial Plast. Surg Clin North Am 13(1):1–10

    Google Scholar 

Download references

Acknowledgments

This study was approved by the Gazi University Ethical Committee for Experimental Research on Animals (Project no: G.U. ET-43-6865) and was financially supported by the Gazi University Research Fund (Project no: 01/2012-60).

Conflict of interest

The authors declare that they have no conflicts of interest to disclose within the blinded manuscript.

Statement of Animal Rights

All applicable institutional and/or national guidelines for the care and use of animals were followed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suhan Ayhan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bulam, H., Ayhan, S., Sezgin, B. et al. The Inhibitory Effect of Platelet-Rich Plasma on Botulinum Toxin Type-A: An Experimental Study in Rabbits. Aesth Plast Surg 39, 134–140 (2015). https://doi.org/10.1007/s00266-014-0418-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-014-0418-z

Keywords

Navigation